Follow the Abpro Holdings, Inc. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €1.5m. The latest transaction was filed on 4 August 2025 (Acquisition). Among the most active insiders: Suk Jin Wook (Miles). All data is openly available.
7
Insider Decl.
n/a
Thresholds
€24,199
4 ops.
Buy Volume
n/a
n/a
Sell Volume
39Σ signal
Buys €24,199n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
91,900 shares0Common Stock, par value $0.0001 per shareSEC:0001474506-24-000247:0
7 of 7 declarations
About Abpro Holdings, Inc.
Abpro Holdings, Inc. is a NASDAQ-listed company specializing in the development of antibody-based therapies. It focuses on innovative solutions for treating various diseases.